Guardion Health Sciences is a specialty health sciences company that develops, formulates and distributes condition-specific medical foods with an initial medical food product that addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration ('AMD'), and a significant component of functional vision performance. The company also develops a proprietary medical device, the MapcatSF, which accurately measures the macular pigment density, therefore providing the only two-pronged evidence-based protocol.